GLPG

#7024
Galapagos NV
33.6600
+1.29%
Sector:
Base:
Profit Currency:
Daily Range
33.6600
33.6600
Year Range
29.8080
36.2200
Daily Change
+1.29%
Monthly Change
-2.77%
6 month change
+4.86%
Year Change
+4.86%
Previous Close
33.2300
Open
33.6600
Bid
Ask
Low
33.6600
High
33.6600
Volume
18
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24 TTM

Galapagos NV - American Depositary Shares

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis.

News